Delivery Order SPE2DB22D3501-SPE2DB24FVS14
Award Date
5/20/24
Potential Completion Date
5/21/24
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Entecavir 0.5 mg tablets. The contract has a total ceiling value of $10,948.32 and runs through January 31, 2025. It is a firm-fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a $1,777.42 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Entecavir 0.5 mg tablets and has an ultimate completion date of November 8, 2024. The contract is not designated with a set-aside. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,630.72 firm-fixed-price delivery order is for the supply of Entecavir 0.5 mg tablets. The contract has an ultimate completion date of June 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,309.60 firm fixed-price contract is for the delivery of 4559908027 Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The contract has an ultimate completion date of February 13, 2023. AmerisourceBergen is a for-profit organization...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,532.79 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,150,864 units of the prescription medication Entecavir 0.5 mg tablets. This delivery order is a part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA. The IDC serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a $1,743.42 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,565,827,750 units of the prescription drug Entecavir 0.5 mg tablets. This contract has an ultimate completion date of September 17, 2024 and was awarded on September 16, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several large Indefinite Delivery Contracts (IDCs) with federal agencies,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The $12,994.06 order is for the supply of Entecavir 0.5 mg tablets to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,758.86 Firm Fixed Price Delivery Order is for the supply of 4564950562 - Entecavir 0.5 mg Tablet 30s, with a period of performance through June 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,179.16, is for the delivery of Entecavir 0.5 mg tablets, a prescription medication. The contract has a completion date of August 10, 2023 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product Entecavir 1 mg tablet in 30-count packages. The contract has a firm fixed price of $6,411.89 and a completion date of July 30, 2024. It is not designated as a set-aside contract. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen leverages its extensive supply chain to provide...